Similar Items: Noncoding RNA Transcripts Based Molecular Phenotyping of MASLD and MASH Patients
- Liver Fibrosis Tests and Outcomes of Bariatric Surgery in Morbidly Obese Patients With MASLD
- Correction to “Liver Fibrosis Tests and Outcomes of Bariatric Surgery in Morbidly Obese Patients With MASLD”
- From HBV to MASLD Cirrhosis: Mechanistic Insights and Therapeutic Strategies
- The Economic Burden of Metabolic Dysfunction‐Associated Steatohepatitis (MASH) With Cirrhosis: A Systematic Review
- Fast Quantitative Evaluation of the Amelioration Effect in MASLD During Semaglutide Treatment Using Ultrasound‐Derived Fat Fraction and Fat‐to‐Muscle Ratio
- 29 | RNA-based combinatorial multi-target therapy for the treatment of Duchenne muscular dystrophy